BusinessIndustries

Global Blood Plasma Derivatives market is valued at 24800 million US$ in 2018 is expected to reach 52000 million US$ by the end of 2025, growing at a CAGR of 9.7% during 2019-2025

Global Blood Plasma Derivatives Market Research Report 2019

Blood plasma is the liquid component of blood constituting of water along with plasma components such as immunoglobulin, electrolytes, glucose, clotting factors, electrolytes, and hormones. It plays a crucial role in maintaining the electrolyte and osmotic balance while preventing infection and blood disorders in the body. Plasma derivatives are the concentrates of specific proteins, which require pooling of plasma from large number of donors. For instance, they require more than hundred plasma donations to produce sufficient immunoglobulin to treat an immune-deficient patient for one year. They are obtained by the process of fractionation where protein concentrates are separated and then clinically used.
The growth of the global blood plasma derivatives market is majorly driven by increase in prevalence of life-threatening disorders, especially hemophilia. factors boosting the market growth include rise in adoption of blood plasma derivatives products, upsurge in geriatric population across the world, and increase in awareness about blood & plasma donation. However, factors such as high cost of plasma derivative-based therapy and post-operative risks associated with plasma replacement therapy hamper the market growth. Conversely, the development of enhanced methods for preservation of plasma derivatives along with advanced procedures for fractionation and high potential in untapped markets in the emerging economies are expected to provide lucrative growth opportunities for the market.

The global Blood Plasma Derivatives market is valued at 24800 million US$ in 2018 is expected to reach 52000 million US$ by the end of 2025, growing at a CAGR of 9.7% during 2019-2025.
This report focuses on Blood Plasma Derivatives volume and value at global level, regional level and company level. From a global perspective, this report represents overall Blood Plasma Derivatives market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The report includes an in-depth analysis of the competitive landscape of this business vertical, constituting manufacturers like:
Grifols
SK Plasma
Fusion Health Care
Biotest AG
Green Cross Corporation
Baxter International
LFB
Octapharma AG
CSL Limited
Shire Plc.
China Biologic Products
Kedrion Biopharma
BDI Pharma
Bayer AG
Hualan Biological Engineering

Market Segment by Regions includes:
North America
Europe
China
Japan

Products Segmentation, this report displays the production, revenue, price, market share, and growth rate of each type as below:
Albumin
Factor VIII
Factor IX
Immunoglobulin
Hyperimmune Globulin

By Industrial Application, the market can be split into:
Hospitals
Clinics
End Users

Market Segment by Regions includes:

  • North America (the USA, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, and Italy)
  • Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
  • South America
  • Middle East and Africa.

Browse contents of Global Blood Plasma Derivatives Market Research Report 2019

Contacts

Trusted Business Insights
Joseph Anthony Jones
Senior Media & Marketing Executive
US: +1 646 568 9797
UK: +44 330 808 0580

Tags

Related Articles

Close